CD30 CAR T-cells
/ New York Medical College
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 18, 2024
CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma
(clinicaltrials.gov)
- P1/2 | N=21 | Not yet recruiting | Sponsor: New York Medical College | Trial completion date: Dec 2041 ➔ Dec 2040 | Initiation date: Jun 2025 ➔ Dec 2024 | Trial primary completion date: Dec 2040 ➔ Dec 2039
CAR T-Cell Therapy • Trial completion date • Trial initiation date • Trial primary completion date • Bone Marrow Transplantation • Hematological Malignancies • Hodgkin Lymphoma • Lymphoma • Oncology • Transplantation • TNFRSF8
1 to 1
Of
1
Go to page
1